Protective effect of Terminalia chebula against experimental myocardial injury induced by isoproterenol

Indian Journal of Experimental Biology

Volumn 42, Issue 2, 2004, Pages 174-178

  Suchalatha, S ^a   Shyamala Devi, C S ^a,b  

^a UNIVERSITY OF MADRAS   (India)

^b NONE   (India)

Author keywords

Isoproterenol; Lipid peroxide; Marker enzymes; Myocardial infarction; Terminalia chebula

Indexed keywords

BODY FLUIDS; CARDIOVASCULAR SYSTEM; ENZYMES; ORGANIC COMPOUNDS;

CARDIOPROTECTIVE EFFECTS; SERUM;

BIOCHEMISTRY;

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ISOPRENALINE; LACTATE DEHYDROGENASE; LIPID PEROXIDE; PLANT EXTRACT;

ANIMAL; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; FRUIT; HEART; HEART INFARCTION; NECROSIS; PATHOLOGY; PHYSIOLOGY; PHYTOTHERAPY; RAT; TERMINALIA;

ADRENERGIC BETA-AGONISTS; ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; FRUIT; HEART; ISOPROTERENOL; L-LACTATE DEHYDROGENASE; LIPID PEROXIDES; MYOCARDIAL INFARCTION; NECROSIS; PHYTOTHERAPY; PLANT EXTRACTS; RATS; TERMINALIA;

ANIMALIA; TERMINALIA; TERMINALIA CHEBULA;

EID: 1042278636     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Nandkarni K M, in Indian Materia Medica, Vol.1, (Popular Prakashan, Bombay, India) 1976, 1206.
2. rd edition (International Book Distributors, Dehradun, India) 1988, 1020.
3. Sabu M C & Kuttan R, Antidiabetic activity of medicinal plants and its relationship with their antioxidant property, J Ethnopharmacol, 81 (2002) 155.
4. Shaila H P & Udupa S L, Hypolipidemic activity of three indigenous drugs in experimentally induced atherosclerosis, Int J Cardiol, 67 (1998) 119.
5. Jain A K, Shimoi K, Nakamura Y, Tomita I & Kada T, Preliminary study on the desmutagenic and antimutagenic effect of some natural products, Curr Sci, 56 (1987) 266.
6. Thatte U & Dahanukar S, Rasayana concept: Clues from immuno-modulatory therapy, in Immunomodulation, edited by S N Upadhyay, (Narosa Publishing House, New Delhi, India) 1997, 141.
7. Sharma A & Singh R H, Screening of antiinflammatory activity of certain indigenous drugs on carrageenin induced hind paw oedema, Bull Med Ethno Bot Res, 1 (1980) 262.
8. Kim et al., Antioxidant effectiveness of ether extract of Crataegus pinnatifida and T. chebula, Hanguk Nonghwa Hakhoechi, 36 (1993) 203.
9. Ammar S, Markku A, Kaleri P, Total phenolics concentration and antioxidant potential of extracts of medicinal plants of Pakistan, Z Naturforsch, 56 (2001) 973.
10. Suresh Kumar J S & Menon V P, Changes in levels of LPO and activity of superoxide dismutase and catalase in diabetes associated with myocardial infarction, Indian J Exp Biol, 30 (1992) 122.
11. Tipnis U P, He G Y, Li S, Campbell G & Boor P J, Attenuation of isoproterenol-mediated myocardial injury in rat by an inhibitor of polyamine synthesis, Cardiovasc Pathol, 9 (2000) 273.
12. Nieland A A, Lactic acid dehydrogenase of heart muscle, Methods Enzymol, I (1985) 449.
13. Norman Hall & Marlene Deluca, Electrophoretic separation and quantification of creatine kinase isoenzymes, Anal Biochem, 16 (1967) 561.
14. Mohur A F & Cooke I J Y, Simple method of measuring serum level of glutamate oxaloacetic acid and glutamate pyruvate transaminase in routine laboratories, J Clin Pathol, 10 (1975) 394.
15. Okhawa H, Onishi N & Yagi K, Assay of lipid peroxidation in animal tissue by thiobarbituric acid reaction, Anal Biochem, 95 (1970) 351.
16. Lowry O H, Rosebrough N J, Farr A L & Randall R J, Protein measurement with the Folin phenol reagent, J Biol Chem, 193 (1951) 265.
17. Sheela S C & Shyamala Devi C S, Protective effect of Abana, a polyherbal formulation on isoproterenol induced myocardial infarction in rats, Indian J Pharmacol, 32 (2000) 198.
18. Saxena K K, Gupta B, Srivastava V K, Singh R C & Prasad D N, Creatine kinase and aspartate transaminase in experimental model to predict size of cardiac infarct, Indian J Exp Biol, 26 (1988) 235.
19. Satish V, Ebenezar K K & Devaki T, Synergistic effect of nicorandil and amlodipine on mitochondrial function during isoproterenol induced myocardial infarction in rats, J Pharm Pharmacol, 54 (2002) 133.
20. Sharma M, Kishore K, Gupta S K, Joshi S & Arya D S, Cardioprotective potential of Ocimum sanctum in isoproterenol induced myocardial infarction in rats, Mol Cell Biochem, 225 (2001) 75.
21. Paritha Ithayarasi, Padmavathy V N & Shyamala Devi C S, Effect of α-tocopherol on isoproterenol induced myocardial infarction in rats - Electrocardiographic, biochemical and histological evidences, Indian J Physiol Pharmacol, 40 (1996) 297.
22. Tipnis U R, He G Y, Li S, Campbell G & Boor P J, Attenuation of isoproterenol-mediated myocardial injury in rats by an inhibitor of polyamine synthesis, Cardiovasc Pathol, 9 (2000) 273.
23. Hagar H, Folic acid and vitamin 812 supplementation attenuates isoprenaline induced myocardial infarction in experimental hyper homocysteinemic rats, Pharmacol Res, 46 (2002) 213.
24. Manjula T S, Geetha A & Shyamala Devi C S, Effect of aspirin on isoproterenol induced myocardial infarction - A pilot study, Indian J Biochem Biophys, 29 (1992) 378.
25. Gao F, Chen J, Lopez B L, Christopher T A, Juanli G, Paul L, Robert R, Xin L M, Hlstein EH & Tian-Li Y, Comparison of bisoprolol and carvedilol, cardioprotection in a rabbit ischemia and reperfusion model, Eur J Pharmacol, 406 (2000) 109.
26. Hung L M, Chen J K, Lee R S, Luang H C & Jai Su M, Beneficial effects of astringinin a resveratrol analogue, on the ischemia and reperfusion damage in rat heart, Free Radic Biol Med, 30 (2001) 877.
27. Inamdar M C & Rajarama Rao M R, Studies on the pharmacology of T. chebula (Retz.), Department of Chemical Technology, University of Bombay, 6 April 1962.
28. Srivastava R D, Dwivedi S, Sreenivasan K K & Chandrasekhar C N, Cardiovascular effects of Terminalia species of plants, Indian Drugs, 29 (1991) 144.
29. Harada K, Fukata Y, Miwa A, Kaneta S, Fukushima H & Ogawa N, Effect of KRN 2391, a novel vasodilator, on various experimental anginal models in rats, JPN J Pharmacol, 63 (1993) 35.
30. Guan Y Y, Kwan C Y, Hsu F L & Cheng J T, In vitro inhibitory effects of chebulinic acid on the contractile responses of cardiovascular muscles, Clin Exp Pharmacol Physiol, 23 (1996) 747.
31. Kato Y, Nagao A, Terao J & Osawa T, Inhibition of myeloperoxidase-catalyzed tyrosylation by phenolic antioxidants in vitro, Biosci Biotechnol Biochem, 67 (2003) 1136.
32. Roginsky V, Chain breaking antioxidant activity of natural polyphenols as determined during the chain oxidation of methyl linoleate in Triton X-100 micelles, Arch Biochem Biophys, 414 (2003) 261.
33. Duarte J, Vizcaino F P, Utrilla P, Jimenez J, Tamargo J & Zazzuelo A, Vasodilatory effects of flavonoids in rat aortic smooth muscles: Structure-activity relationships, Biochem Pharmacol, 24 (1993) 857.
34. Hanaski Y, Ogawa S & Fukui S, The correlation between active oxygen scavengers and antioxidative effects of flavonoids, Free Rad Biol Med, 16 (1994) 845.
35. Tzeng S H, Ko W C, Ko F N & Tzeng C M, Inhibition of platelet aggregation by some flavonoids, Thromb Res, 64 (1991) 91.